RMD Open
(Dec 2021)
Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab
- Axel Finckh,
- Benoît Gilbert,
- Diana Dan,
- Laure Brulhart,
- Cathy Mireille Melong Pianta Taleng,
- Tim Cunningham,
- Romain Guemara
Affiliations
- Axel Finckh
- Divison of Rheumatology, Department of Internal Medicine, Geneva University Hospitals, Geneve, Switzerland
- Benoît Gilbert
- Divison of Rheumatology, Department of Internal Medicine, Geneva University Hospitals, Geneve, Switzerland
- Diana Dan
- Division of Rheumatology, Lausanne University Hospital (CHUV), Lausanne, Switzerland
- Laure Brulhart
- Rheumatology, Network Hospital Neuchâtel, Neuchatel, Switzerland
- Cathy Mireille Melong Pianta Taleng
- Divison of Rheumatology, Department of Internal Medicine, Geneva University Hospitals, Geneve, Switzerland
- Tim Cunningham
- Rheumatology, Private Practice, Geneva, Switzerland
- Romain Guemara
- Rheumatology, Network Hospital Neuchâtel, Neuchatel, Switzerland
- DOI
-
https://doi.org/10.1136/rmdopen-2021-001711
- Journal volume & issue
-
Vol. 7,
no. 3
WeChat QR code